Referenzen
Produkte Transfektion
Kostenlose Testsamples
Anwendungshinweise:
Im „Transfection Reagent Selection Guide“ können Sie durch Filterfunktionen z.B. für Ihre Kombination aus zu transfizierender Zelle und Nukleinsäure die Liste vorhandener Referenzen durchsuchen. Ebenso können Sie im Feld „Referenzen durchsuchen“ am Anfang der Seite mit passenden Schlagwörtern zu einem Ergebnis gelangen. Eine Referenz zeigt an, dass das gefundene Transfektionsreagenz bereits erfolgreich für die entsprechende Anwendung verwendet wurde. Im Idealfall sind getestete Transfektionsparameter und Transfektionseffizienzen angegeben.
Keine Referenz? > Allgemeine Auswahlhilfe
Wenn Sie keine Referenz gefunden haben, heißt das nicht, dass kein passendes Reagenz zur Verfügung steht, sondern lediglich, dass bisher keine Erfahrungsberichte vorliegen. In diesem Falle kann durch eine Vorauswahl ein erfolgsversprechendes Transfektionsreagenz ausgewählt (Allgemeine Auswahlhilfe) und letztendlich ausgetestet (Kostenlose Testsamples) werden. Wenn Sie einen Erfahrungsbericht für uns schreiben möchten machen wir Ihnen ein Angebot für eine Gegenleistung.
CELL TYPE | DESCRIPTION OF CELL TYPE | CAT.NO. | SPECIES | ORIGIN OF CELLS | COMMON CELL TYPE | GROWTH PROPERTIES | NUCLEIC ACID / DELIVERED MOLECULE | APPLICATION | PRODUCT | REFERENCE TYPE | BIBLIOGRAPHIC DATA | LINK | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene | publication | P. J. Hodul et al., PLoS ONE, 2013, 8(2): e52526. doi:10.1371/journal.pone.0052526 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Oncotarget, 2016, 7 (14): 17726-17736 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | P. J. Hodul et al., PLoS ONE, 2013, 8(2): e52526. doi:10.1371/journal.pone.0052526 | Link | |
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin et al., Mol. Pharmacol., Oct 2014; 86: 561 - 569 | ||
MIA PaCa-2 |
Human pancreas carcinoma cell line | ATCC CRL-1420 | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Qin, PhD Thesis, 2014, Indiana University | ||
mIMCD3 |
Mouse kidney inner medullary collecting duct (IMCD) cell line | ATCC CRL-2123 | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | J. L. Cano-Penalver et al., Mol. Med., 2015, 21:873-885; doi: 10.2119/molmed.2015.00059 | Link | |
mIMCD3 |
Mouse kidney inner medullary collecting duct (IMCD) cell line | ATCC CRL-2123 | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | J. L. Cano-Penalver et al., The FASEB J., 2014, 28 (8): 3645-3659, doi: 10.1096/fj.13-249250 | Link | |
mIMCD3 |
Mouse kidney inner medullary collecting duct (IMCD) cell line | ATCC CRL-2123 | Mouse | urinary system | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | M. Hatem-Vaquero et al., BBA - Gene Regulatory Mechanisms, 2017, 1860: 922-935 | ||
mIMCD3 |
Mouse kidney inner medullary collecting duct (IMCD) cell line | ATCC CRL-2123 | Mouse | urinary system | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | W.-C. Lee et al., Am J Physiol Renal Physiol, Oct 2010; 299: F740 - F751 | Link | |
MIN6 |
Mouse insulinoma pancreatic beta cell line | Mouse | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Hu et al., Sci Rep 10, 2020, 17581, doi.org/10.1038/s41598-020-74593-w | Link | ||
MIN6 |
Mouse insulinoma pancreatic beta cell line | Mouse | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | R. Fernandez-Ruiz et al., PLoS ONE, 2014, 9(2): e90344, doi:10.1371/journal.pone.0090344 | Link | ||
MIN6 |
Mouse insulinoma pancreatic beta cell line | Mouse | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | E. H. Han et al., PLoS ONE, 2012, 7(8): e44007, doi:10.1371/journal.pone.0044007 | Link | ||
MIN6 |
Mouse insulinoma pancreatic beta cell line | Mouse | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | E. H. Han et al., Biochem. and Biophys. Res. Commun., 2015, 468:14-20; doi.org/10.1016/j.bbrc.2015.11.007 | |||
MIN6 |
Mouse insulinoma pancreatic beta cell line | Mouse | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | Y. Luo et al., PLoS ONE, 2014, 9(6): e99049, doi:10.1371/journal.pone.0099049 | Link | ||
MIN6 |
Mouse insulinoma pancreatic beta cell line | Mouse | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | L. Hu et al., bioRxiv preprint, 2019, doi: https://doi.org/10.1101/2020.01.11.902916 | Link | ||
MIN6 |
Mouse insulinoma pancreatic beta cell line | Mouse | digestive organs | cell line | adherent | plasmid | RNA-Interference | Metafectene PRO | publication | E. H. Han et al., J. Biol. Chem., 2019, doi/10.1074/jbc.RA119.009558 | Link | ||
MKN-28 |
Human gastric cancer cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | C. A. T. Resende, PhD Thesis, 2014, Universidade do Porto | |||
MKN45 |
Human gastric adenocarcinoma cell line | Human | digestive organs | cell line | siRNA | RNA-Interference | Metafectene PRO | publication | S. V. Rao et al., BMC Cancer, 2017, 17:68, DOI 10.1186/s12885-017-3055-5 | Link | |||
MOVAS-1 |
Mouse aorta smooth muscle cells | ATCC CRL-2797 | Mouse | vasculature | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | B. Park et al., Bioscience, Biotechnology, and Biochemistry, 2015, 79(4): 539-552; DOI: 10.1080/09168451.2014.991681 | Link | |
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | M. .I Koukourakis et al., Laboratory Investigation, 2017, 97: 1321-1331, doi:10.1038/labinvest.2017.79 | ||
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene | publication | M. Alagoz et al., Nucleic Acids Res., Mar 2014; 42: 3089 - 3103 | Link | |
MRC5 |
Human fetal lung fibroblast cell line | ATCC CCL-171 | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | S.-C. Chiang, University of Sussex | Link | |
MRC5VA |
Human SV40-transformed lung fibroblast cell line | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz et al., Hum. Mol. Genet., Dec 2016, DOI: 10.1093/hmg/ddw364 | |||
MRC5VA |
Human SV40-transformed lung fibroblast cell line | Human | respiratory system | cell line | adherent | siRNA | RNA-Interference | Metafectene PRO | publication | I. Abramowicz ez al., HMG Advance Access, 2016 | |||
Mz-ChA-2 |
Human extrahepatic biliary tract gallbladder carcinoma cell line | Human | digestive organs | cell line | adherent | siRNA | RNA-Interference | Metafectene SI | publication | N. Golob‑Schwarzl et al., J. of Cancer Res. and Clin. Oncology, 2019, 145: 2699–2711, doi.org/10.1007/s00432-019-03030-x | Link |